**Core Concept**
The underlying principle being tested is the appropriate management of a pregnant patient with a history of hypertension, currently taking **enalapril**, an **angiotensin-converting enzyme (ACE) inhibitor**.

**Why the Correct Answer is Right**
Although the question does not specify the correct answer choice, in a pregnant patient with hypertension, it's crucial to monitor for potential complications. Given the patient's history of hypertension and current pregnancy, tests for **proteinuria** or **preeclampsia** screening would be essential, as **ACE inhibitors** are contraindicated in pregnancy due to the risk of **fetal renal damage** and other complications.

**Why Each Wrong Option is Incorrect**
**Option A:** Without the specific test mentioned, it's challenging to provide a detailed explanation. However, any option that does not prioritize the patient's hypertensive condition and its implications on pregnancy would be incorrect.
**Option B:** Similarly, without specifics, it's hard to comment, but tests unrelated to hypertension or fetal well-being would not be the priority.
**Option C:** Again, lacking specifics, but tests not focused on maternal or fetal health in the context of hypertension in pregnancy would be inappropriate.
**Option D:** This option is also unspecified, but any choice that ignores the need for monitoring the effects of hypertension and **enalapril** use in pregnancy would be wrong.

**Clinical Pearl / High-Yield Fact**
It's crucial to remember that **ACE inhibitors** are contraindicated in pregnancy due to potential **fetal harm**, and alternative antihypertensive medications should be considered. Regular monitoring of blood pressure and fetal well-being is essential.

**Correct Answer:** D. Urine protein/creatinine ratio